Signifor® LA 40 mg


Powder for suspension for injection
scheduling status
S4
registration number
49/32/0273
What Signifor® LA 40 mg contains
Pasireotide (as pamoate).
other ingredients
Vial: Poly(D,L-lactide-co-glycolide) (50-60:40-50), Poly(D,L-lactide-co-glycolide) (50:50) Pre-filled syringe: Carmellose sodium, mannitol, poloxamer 188, water for injections.
Therapeutic classification
H01CB05.
© 2026 SAHPRA. ALL RIGHTS RESERVED